Cas:2937-61-3 2-Hydroxy-1,3,5-Benzenetrimethanol manufacturer & supplier

We serve Chemical Name:2-Hydroxy-1,3,5-Benzenetrimethanol CAS:2937-61-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Hydroxy-1,3,5-Benzenetrimethanol

Chemical Name:2-Hydroxy-1,3,5-Benzenetrimethanol
CAS.NO:2937-61-3
Synonyms:2,4,6-Trimethylolphenol;2,4,6-Tris-hydroxymethyl-phenol;2,4,6-trihydroxymethylphenol;1,3,5-Benzenetrimethanol,2-hydroxy;2-Hydroxybenzene-1,3,5-trimethanol;EINECS 220-921-3;2,3-DIMETHOXYCINNAMIC ACID;2-Hydroxy-1,3,5-Benzenetrimethanol
Molecular Formula:C9H12O4
Molecular Weight:184.18900
HS Code:2907199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:416.7ºC at 760mmHg
Density:1.424g/cm3
Index of Refraction:1.655
PSA:80.92000
Exact Mass:184.07400
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,4,6-Trimethylolphenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Hydroxy-1,3,5-Benzenetrimethanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-DIMETHOXYCINNAMIC ACID Use and application,2-Hydroxy-1,3,5-Benzenetrimethanol technical grade,usp/ep/jp grade.


Related News: The data will be updated at the upcoming 2019 ASH Annual Meeting next week. 2-Hydroxy-1,3,5-Benzenetrimethanol manufacturer We manufacture APIs and drug manufacturers make medicines from APIs. 2-Hydroxy-1,3,5-Benzenetrimethanol supplier New Zealand on Sunday became the latest country to impose restrictions on travelers from mainland China, saying it would deny entry to visitors departing from or transiting through the mainland for two weeks starting on Monday. 2-Hydroxy-1,3,5-Benzenetrimethanol vendor Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 2-Hydroxy-1,3,5-Benzenetrimethanol factory The data will be updated at the upcoming 2019 ASH Annual Meeting next week.